When should osteoporosis be suspected in children or adolescents and how is it diagnosed, including clinical criteria, dual‑energy X‑ray absorptiometry (DXA) imaging, and laboratory evaluation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Suspect Osteoporosis in Children and Adolescents

Osteoporosis in children and adolescents should be suspected when there is a low-trauma vertebral compression fracture (even a single one), OR when there are two or more long bone fractures of the lower extremities, OR when there is low bone mineral density (Z-score ≤ -2.0) combined with a clinically significant fracture history. 1

Clinical Scenarios Requiring High Suspicion

Primary Risk Factors for Screening

Chronic glucocorticoid therapy (≥6 months) is the most common acquired cause requiring bone health surveillance, as steroids directly impair bone formation and increase fracture risk. 2, 3

Prolonged immobilization from conditions like cerebral palsy, Duchenne muscular dystrophy, or spinal cord injury creates severe bone loss through mechanical unloading. 2, 3

Chronic diseases including inflammatory bowel disease, cystic fibrosis, chronic kidney disease, rheumatoid arthritis, and malignancies with chemotherapy exposure all compromise bone accrual during critical growth periods. 1, 3

Endocrine disorders such as hypogonadism, growth hormone deficiency, hyperthyroidism, and Cushing syndrome directly impair peak bone mass attainment. 2, 4

Nutritional deficiencies particularly in eating disorders, malabsorption syndromes, or functional hypothalamic amenorrhea in female athletes with low energy availability. 1

Specific Red Flags in History

Menstrual dysfunction in adolescent females—delayed menarche (>15 years), amenorrhea, or oligomenorrhea (≤6-8 menses per year)—strongly predicts compromised bone health. 1

Low body mass index (<17.5-18.5 kg/m²) or recent weight loss (5-10% in one month) indicates inadequate energy availability affecting bone metabolism. 1

Recurrent low-trauma fractures especially of vertebrae, long bones of lower extremities, or multiple upper extremity fractures warrant immediate evaluation. 1, 2

Medications including depot medroxyprogesterone acetate, anticonvulsants, chronic heparin, androgen deprivation therapy, or aromatase inhibitors for ≥6 months. 1

Family history of early-onset osteoporosis or genetic bone disorders (osteogenesis imperfecta, hypophosphatasia) suggests inherited bone fragility. 2, 5


How to Diagnose Osteoporosis in Children and Adolescents

Diagnostic Criteria: The Critical Distinction

The diagnosis of osteoporosis in children and adolescents CANNOT be made on bone mineral density alone—it requires BOTH low BMD (Z-score ≤ -2.0) AND a clinically significant fracture history. 1

Exception to the Rule

A single low-trauma vertebral compression fracture alone is sufficient to diagnose osteoporosis, regardless of BMD. 1, 5

Clinically Significant Fracture History Defined

  • One or more vertebral compression fractures 1
  • One long bone fracture of the lower extremities (femur, tibia excluding ankle) 1
  • Two or more long bone fractures of the upper extremities 1

Important Caveat

A Z-score > -2.0 does NOT exclude osteoporosis if there are vertebral fractures or multiple low-trauma long bone fractures in the appropriate clinical context (e.g., chronic steroid use, immobilization). 1, 5


DXA Imaging: Technical Requirements

Which Sites to Measure

For children and adolescents <20 years:

  • Posteroanterior lumbar spine (L1-L4) for bone mineral content (BMC) and areal BMD 1
  • Whole body less head (or whole body if unavailable) for BMC and areal BMD 1
  • Lateral distal femur when other sites are not measurable (e.g., severe contractures, hardware) 1

Do NOT measure hip/femoral neck in growing children as reference data are less reliable and interpretation is problematic during growth. 1

Critical Adjustments Required

In children with short stature or growth delay, BMD MUST be adjusted:

  • For spine: Use bone mineral apparent density (BMAD) or height Z-score adjustment 1
  • For total body less head: Adjust using height Z-score 1
  • Use pediatric reference data specific to age, sex, and ethnicity 1

Failure to adjust for body size leads to overdiagnosis of osteoporosis in constitutionally small children. 1, 5

Scoring System: Z-Scores NOT T-Scores

Always use Z-scores (age- and sex-matched) in children, adolescents, premenopausal women, and men <50 years. 1

NEVER use T-scores or WHO criteria (T-score ≤ -2.5) in pediatric populations—this is a critical error that leads to misdiagnosis. 1, 6

Z-score ≤ -2.0 = "bone mineral density below the expected range for age" (avoid terms "osteopenia" or "osteoporosis" based on BMD alone). 1

When to Perform DXA Screening

High-risk indications for baseline DXA:

  • Chronic glucocorticoid therapy ≥3 months (or anticipated ≥3 months) 2, 3
  • History of low-trauma vertebral or long bone fracture 1
  • Chronic disease with known bone fragility risk (see above) 3
  • Prolonged immobilization or non-ambulatory status 2, 3
  • Delayed puberty, amenorrhea >6 months, or eating disorder 1

Repeat DXA frequency:

  • Every 6-12 months in high-risk patients on treatment or with ongoing risk factors 1, 3
  • After at least 1 year interval to detect meaningful change (must exceed least significant change of ~3-5%) 1

Laboratory Evaluation: Identifying Secondary Causes

Essential Initial Workup

Complete blood count to screen for anemia, malignancy, or chronic inflammation. 2

Comprehensive metabolic panel including calcium, phosphate, alkaline phosphatase, creatinine, and liver function tests. 2

25-hydroxyvitamin D level (target >30 ng/mL; deficiency <20 ng/mL impairs bone mineralization). 2, 3

Parathyroid hormone (PTH) to assess for primary or secondary hyperparathyroidism. 2

Thyroid function tests (TSH, free T4) as hyperthyroidism accelerates bone turnover. 2

Endocrine Assessment in Appropriate Contexts

In females with menstrual irregularities:

  • Luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol 1
  • Pregnancy test (β-hCG) 1
  • Prolactin if amenorrhea present 1

In males with delayed puberty or hypogonadism:

  • Total testosterone, LH, FSH 2

If growth delay or short stature:

  • Insulin-like growth factor 1 (IGF-1), IGF binding protein 3 2
  • Consider growth hormone stimulation testing 2

Bone Turnover Markers (Optional)

Serum procollagen type I N-propeptide (P1NP) for bone formation and serum C-terminal telopeptide of type I collagen (CTX) for bone resorption can assess bone metabolism, though interpretation is challenging due to age-related variability. 1

These markers are NOT required for diagnosis but may help monitor treatment response. 1

Genetic Testing When Indicated

Consider genetic evaluation if:

  • Multiple vertebral fractures with minimal trauma 2, 5
  • Family history of early-onset osteoporosis 2, 5
  • Blue sclerae, dentinogenesis imperfecta, or other skeletal dysplasia features 2, 5
  • Unexplained severe osteoporosis without clear secondary cause 2, 5

Gene panels for osteogenesis imperfecta, hypophosphatasia, and other monogenic bone disorders are increasingly available. 2, 5


Vertebral Fracture Assessment: The Often-Missed Component

Vertebral compression fractures are common in pediatric osteoporosis but frequently asymptomatic—they will be missed without systematic screening. 3, 5

Lateral spine radiographs (T4-L4) should be obtained in all high-risk patients, even without back pain. 3, 5

Vertebral fracture assessment (VFA) by DXA is an alternative lower-radiation option for screening, though lateral spine X-rays provide better detail. 3

A single vertebral compression fracture is diagnostic of osteoporosis regardless of BMD. 1, 5


Common Pitfalls and How to Avoid Them

Pitfall #1: Using T-scores instead of Z-scores in pediatric patients. This applies adult diagnostic criteria inappropriately and leads to overdiagnosis. Always use Z-scores. 1, 6

Pitfall #2: Diagnosing osteoporosis based on low BMD alone without fractures. A Z-score ≤ -2.0 is "low bone density for age" but NOT osteoporosis unless there are clinically significant fractures. 1

Pitfall #3: Failing to adjust BMD for body size in short or growth-delayed children. Unadjusted BMD systematically underestimates bone health in small children. Use height-adjusted Z-scores. 1, 5

Pitfall #4: Missing asymptomatic vertebral fractures. Up to 50% of vertebral fractures in children are painless. Screen with lateral spine imaging in all high-risk patients. 3, 5

Pitfall #5: Attributing all fractures to "normal childhood activity" without considering fracture characteristics. Low-trauma fractures (fall from standing height or less) in weight-bearing bones warrant evaluation, especially if recurrent. 5

Pitfall #6: Ignoring the clinical context. A child on chronic steroids with a single femur fracture from minimal trauma likely has osteoporosis even if Z-score is -1.5. Clinical judgment matters. 5

Pitfall #7: Comparing serial DXAs from different machines or facilities. Precision errors make cross-machine comparisons unreliable. Use the same DXA system for follow-up. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A Contemporary View of the Definition and Diagnosis of Osteoporosis in Children and Adolescents.

The Journal of clinical endocrinology and metabolism, 2020

Guideline

Interpreting T-scores for Osteoporosis Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.